TY - JOUR
T1 - NeuCode Proteomics Reveals Bap1 Regulation of Metabolism
AU - Baughman, Joshua M.
AU - Rose, Christopher M.
AU - Kolumam, Ganesh
AU - Webster, Joshua D.
AU - Wilkerson, Emily M.
AU - Merrill, Anna E.
AU - Rhoads, Timothy W.
AU - Noubade, Rajkumar
AU - Katavolos, Paula
AU - Lesch, Justin
AU - Stapleton, Donald S.
AU - Rabaglia, Mary E.
AU - Schueler, Kathy L.
AU - Asuncion, Raymond
AU - Domeyer, Melanie
AU - Zavala-Solorio, Jose
AU - Reich, Michael
AU - DeVoss, Jason
AU - Keller, Mark P.
AU - Attie, Alan D.
AU - Hebert, Alexander S.
AU - Westphall, Michael S.
AU - Coon, Joshua J.
AU - Kirkpatrick, Donald S.
AU - Dey, Anwesha
N1 - Publisher Copyright:
© 2016
PY - 2016/7/12
Y1 - 2016/7/12
N2 - We introduce neutron-encoded (NeuCode) amino acid labeling of mice as a strategy for multiplexed proteomic analysis in vivo. Using NeuCode, we characterize an inducible knockout mouse model of Bap1, a tumor suppressor and deubiquitinase whose in vivo roles outside of cancer are not well established. NeuCode proteomics revealed altered metabolic pathways following Bap1 deletion, including profound elevation of cholesterol biosynthetic machinery coincident with reduced expression of gluconeogenic and lipid homeostasis proteins in liver. Bap1 loss increased pancreatitis biomarkers and reduced expression of mitochondrial proteins. These alterations accompany a metabolic remodeling with hypoglycemia, hypercholesterolemia, hepatic lipid loss, and acinar cell degeneration. Liver-specific Bap1 null mice present with fully penetrant perinatal lethality, severe hypoglycemia, and hepatic lipid deficiency. This work reveals Bap1 as a metabolic regulator in liver and pancreas, and it establishes NeuCode as a reliable proteomic method for deciphering in vivo biology.
AB - We introduce neutron-encoded (NeuCode) amino acid labeling of mice as a strategy for multiplexed proteomic analysis in vivo. Using NeuCode, we characterize an inducible knockout mouse model of Bap1, a tumor suppressor and deubiquitinase whose in vivo roles outside of cancer are not well established. NeuCode proteomics revealed altered metabolic pathways following Bap1 deletion, including profound elevation of cholesterol biosynthetic machinery coincident with reduced expression of gluconeogenic and lipid homeostasis proteins in liver. Bap1 loss increased pancreatitis biomarkers and reduced expression of mitochondrial proteins. These alterations accompany a metabolic remodeling with hypoglycemia, hypercholesterolemia, hepatic lipid loss, and acinar cell degeneration. Liver-specific Bap1 null mice present with fully penetrant perinatal lethality, severe hypoglycemia, and hepatic lipid deficiency. This work reveals Bap1 as a metabolic regulator in liver and pancreas, and it establishes NeuCode as a reliable proteomic method for deciphering in vivo biology.
UR - http://www.scopus.com/inward/record.url?scp=84978532196&partnerID=8YFLogxK
U2 - 10.1016/j.celrep.2016.05.096
DO - 10.1016/j.celrep.2016.05.096
M3 - Article
C2 - 27373151
AN - SCOPUS:84978532196
SN - 2639-1856
VL - 16
SP - 583
EP - 595
JO - Cell Reports
JF - Cell Reports
IS - 2
ER -